Drug Resistant Hiv - Infectious Diseases

Relevant Publications

Pharmacovigilance in Pregnancy Studies, Exposures and Outcomes Ascertainment, and Findings from Low- and Middle-Income Countries: A Scoping Review.

Issue Release: 2024

Immunological and molecular assessment of HIV-1 mutations for antiretroviral drug resistance in Saudi Arabia.

Issue Release: 2024

Therapeutic strategies during cenobamate treatment initiation: Delphi panel recommendations.

Issue Release: 2024

Consensus recommendations for the use of novel antiretrovirals in persons with HIV who are heavily treatment-experienced and/or have multidrug-resistant HIV-1: Endorsed by the American Academy of HIV Medicine, American College of Clinical Pharmacy.

Issue Release: 2024

Broad synergistic antiviral efficacy between a novel elite controller-derived dipeptide and antiretrovirals against drug-resistant HIV-1.

Issue Release: 2024

The Phenomenon of Antiretroviral Drug Resistance in the Context of Human Immunodeficiency Virus Treatment: Dynamic and Ever Evolving Subject Matter.

Issue Release: 2024

Amphotericin B resistance in Leishmania amazonensis: In vitro and in vivo characterization of a Brazilian clinical isolate.

Issue Release: 2024

Pharmaco-virological outcomes and genotypic resistance profiles among children and adolescents receiving a DTG-based regimen in Togo.

Issue Release: 2024

PAM-free diagnostics with diverse type V CRISPR-Cas systems.

Issue Release: 2024

Clinical, molecular, and drug resistance epidemiology of HIV in Jordan, 2019-2021: a national study.

Issue Release: 2024

Delineating the evolutionary pathway to multidrug-resistant outbreaks of a Mycobacterium tuberculosis L4.1.2.1/Haarlem sublineage.

Issue Release: 2024

Tuberculosis in Poland in 2021.

Issue Release: 2024

Molecular transmission network and drug resistance in treatment-naïve HIV-1 infected patients in the Liangshan District, China.

Issue Release: 2024

Prevalence, treatment, and outcomes of hepatitis C in an MDR/RR-TB trial cohort.

Issue Release: 2024

Neurosymptomatic HIV-1 CSF escape is associated with replication in CNS T cells and inflammation.

Issue Release: 2024

Design of Novel Imidazole Derivatives as Potential Non-nucleoside Reverse Transcriptase Inhibitors Using Molecular Docking and Dynamics Strategies.

Issue Release: 2024

Age and gender in drug resistance tuberculosis: a cross sectional case study at a national tuberculosis reference hospital in Nigeria.

Issue Release: 2024

Using Acanthamoeba spp. as a cell model to evaluate Leishmania infections.

Issue Release: 2024

HIV-DRIVES: HIV drug resistance identification, variant evaluation, and surveillance pipeline.

Issue Release: 2024

Global, regional, and national burden of HIV-negative tuberculosis, 1990-2021: findings from the Global Burden of Disease Study 2021.

Issue Release: 2024

What Role Do Sporozoites Play in the Disease Cycle?

How Does the NIH Contribute to Infectious Disease Research?

How Do We Diagnose Infections?

What is the Future of PCR in Infectious Diseases?

What are Common Adverse Effects of Antimicrobial Drugs?

What Types of Assays are Used in HTS for Infectious Diseases?

What Are the Components of the DTaP Vaccine?

What are the Symptoms of Hepatitis B?

How Can STIs Be Prevented?

What are the Challenges in Treating Sporozoite-Related Infections?

Partnered Content Networks

Relevant Topics